Clinical Trial: A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07459556) titled 'A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)' on March 05.

Brief Summary: This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.

Study Start Date: March, 2026

Study Type: OBSERVATIONAL

Condition: SAR

Intervention: BIOLOGICAL: Stapokibart

subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chengdu Kangnuoxing Biopharma,Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....